GlycoMantra
PrivateLast Round
Grant
Dec 11, 2023
Total Funding Raised
$4.71M
Company Overview
GlycoMantra operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Grant round in December 2023.
GlycoMantra is a biotechnology company that develops carbohydrate-based therapeutics for cancer, fibrosis, and diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycoMantra Comparables
Compare GlycoMantra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| G3 Pharmaceuticals | 83% | |
| For-Robin, Inc. | 80% | |
| MandalMed, Inc. | 78% |
For institutional investors. Book with your work email.
GlycoMantra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2023 | ||||
| Grant | Sep 18, 2018 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | Jul 1, 2016 | ||||
| Grant | Nov 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GlycoMantra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| TEDCO | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 2146% MoM, reaching 1.7K.
- Apr 3, 2026
Monthly visitors increased 1016% MoM, reaching 826.
For institutional investors. Book with your work email.
GlycoMantra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlycoMantra's valuation, stock price, and market status.
Is GlycoMantra a public or private company?
GlycoMantra is a private company.
What is the current stock price of GlycoMantra?
GlycoMantra is a private company, so its shares have no public market price. Caplight tracks GlycoMantra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlycoMantra worth (valuation)?
Valuation information for GlycoMantra is not publicly available.
Can I buy GlycoMantra stock?
GlycoMantra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlycoMantra's last funding round?
GlycoMantra's most recent funding round was Grant on December 11, 2023.
Who are the main investors in GlycoMantra?
Key investors in GlycoMantra include National Cancer Institute, TEDCO, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH).
Will GlycoMantra IPO soon?
No public IPO plans have been announced for GlycoMantra.
How can I track GlycoMantra secondary market activity?
Caplight tracks bids, offers, and trades in GlycoMantra's shares on secondary markets.